Frontiers in Psychiatry | Psychopharmacology

Original Research

Published on 05 Feb 2025

Lurasidone uses and dosages in Spain: RETROLUR, a real-world retrospective analysis using artificial intelligence

in Psychopharmacology

Fernando Mora
Carlos Gómez Sánchez-Lafuente
Mariano De Iceta
Carolina Roset
Antonio Cárdenas
Daniel Pérez
Elena Álvarez-Barón
Irene Gabarda-Inat
Savana Research Group

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1506142

3,789 views
1 citation

Case Report

Published on 03 Feb 2025

Treatment of neuropathic pain with repeated low-dose MDMA: a case report

in Psychopharmacology

Peter Gasser
Matthias E. Liechti
Friederike Holze

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1513022

13,426 views

Perspective

Published on 23 Jan 2025

Bringing MDMA-assisted therapy for PTSD to traditional healthcare systems: tending to set and setting

in Psychopharmacology

Dimitri Perivoliotis
Kayla Knopp
Shannon Remick
Allie Kaigle
Christopher S. Stauffer
Chandra Khalifian
Tamara R. Wachsman
Bettye E. Chargin
Andrew W. Bismark
Al Alam

Frontiers in Psychiatry

doi 10.3389/fpsyt.2025.1433999

7,498 views

Review

Published on 10 Jan 2025

A systematic review and meta-analysis of the effects of combined aripiprazole on glycolipid metabolism in schizophrenia

in Psychopharmacology

Tianbao Wei
Limei Jiang
Ruilin Zhang
Hang Su
Zhenjie Sun
Junwei Sun

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1496986

2,297 views

Correction

Published on 23 Dec 2024

Corrigendum: Physical disability and psychedelic therapies: an agenda for inclusive research and practice

in Psychopharmacology

Kevin T. Mintz
Brinn Gammer
Amanda J. Khan
Gretchen Shaub
Steven Levine
Dominic Sisti

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1523364

941 views

Original Research

Published on 20 Dec 2024

Clinical pharmacist recommendations in daily interdisciplinary ward rounds at a psychiatric hospital: a retrospective pre-post study on drug-related problems focused in somatic comorbidities

in Psychopharmacology

Matej Stuhec
Anteja Gorjan Gazdag
Zala Cuk
Robert Oravecz
Borjanka Batinic

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1473832

1,956 views
5 citations

Original Research

Published on 09 Dec 2024

Association between polypharmacy and the long-term prescription of hypnotics in Japan: a retrospective cross-sectional study

in Psychopharmacology

Munehiro Komatsu
Masahiro Takeshima
Kazuhisa Yoshizawa
Masaya Ogasawara
Mizuki Kudo
Eru Miyakoshi
Yu Itoh
Nana Shibata
Naoko Ayabe
Kazuo Mishima

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1471457

2,583 views
1 citation

Systematic Review

Published on 09 Dec 2024

Phytochemicals in the treatment of patients with depression: a systemic review

in Psychopharmacology

Natalia Picheta
Julia Piekarz
Karolina Daniłowska
Karol Mazur
Halina Piecewicz - Szczęsna
Agata Smoleń

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1509109

6,489 views
6 citations

Case Report

Published on 04 Dec 2024

Pregabalin treatment in a 30-year-old patient with Bainbridge-Ropers syndrome: a case-report

in Psychopharmacology

Marie Geiser
Jean-Marc Good
Vincent Guinchat

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1502773

3,342 views
1 citation

Systematic Review

Published on 04 Dec 2024

Prevalence and solving strategies of drug-related problems in adult psychiatric inpatients - a systematic review

in Psychopharmacology

Katharina Wien
Pamela Reißner
Gudrun Hefner
Julia Thern
Stefan Borgwardt

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1460098

3,141 views
3 citations

Opinion

Published on 12 Nov 2024

Metformin in the management of antipsychotic-induced weight gain – why the ‘weight’?

in Psychopharmacology

Ita Fitzgerald
Laura J. Sahm
Ciara Ní Dhubhlaing
Sarah O’Dwyer
Jean O’Connell
Jennifer Torrens
Erin K. Crowley

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1491417

6,183 views
2 citations

Editorial

Published on 12 Nov 2024

Editorial: Women in psychiatry 2023: psychopharmacology

in Psychopharmacology

Rosana Camarini
Alfreda Stadlin
Reem Kais Jan

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1488260

1,123 views

Case Report

Published on 07 Nov 2024

Vortioxetine as an alternative treatment for somatic symptom disorder: case report

in Psychopharmacology

Naoki Furutani
Yasuhide Nagoshi

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1496072

4,888 views
4 citations

Opinion

Published on 06 Nov 2024

Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics

in Psychopharmacology

Cristiano Chaves
Rafael G. dos Santos
Serdar M. Dursun
Massimo Tusconi
Mauro Giovanni Carta
Elisa Brietzke
Jaime E. C. Hallak

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1485337

16,419 views
8 citations

Original Research

Published on 01 Nov 2024

Country-specific psychopharmacological risk of reporting suicidality comparing 38 antidepressants and lithium from the FDA Adverse Event Reporting System, 2017–2023

in Psychopharmacology

Andy Roger Eugene

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1442490

4,526 views
6 citations

Editorial

Published on 22 Oct 2024

Editorial: Biological and non-pharmacological treatments of obsessive-compulsive disorder and related disorders

in Psychopharmacology

Renato de Filippis
Samer El Hayek
Mohammadreza Shalbafan

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1494444

2,560 views
1 citation

Original Research

Published on 14 Oct 2024

Hepatotoxicity of antipsychotics: an exploratory pharmacoepidemiologic and pharmacodynamic study integrating FAERS data and in vitro receptor-binding affinities

in Psychopharmacology

René Zeiss
Carlos Schönfeldt-Lecuona
Bernhard J. Connemann
Susanne Hafner
Maximilian Gahr

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1479625

4,363 views
4 citations

Original Research

Published on 04 Oct 2024

Passiflora incarnata L., herba, in benzodiazepine tapering: long-term safety and efficacy in a real-world setting

in Psychopharmacology

Matteo Carminati
Mattia Tondello
Raffaella Zanardi

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1471083

6,117 views
4 citations

Review

Published on 04 Oct 2024

The potential of muscarinic M1 and M4 receptor activators for the treatment of cognitive impairment associated with schizophrenia

in Psychopharmacology

Samantha E. Yohn
Phillip D. Harvey
Stephen K. Brannan
William P. Horan

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1421554

12,081 views
17 citations

Review

Published on 25 Sep 2024

Exploring cariprazine as a treatment option for varied depression symptom clusters

in Psychopharmacology

Bojana Pejušković
Ana Munjiza Jovanović
Danilo Pešić

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1442699

7,901 views
5 citations

Systematic Review

Published on 23 Sep 2024

The safety and efficacy of N-acetylcysteine as an augmentation in the treatment of obsessive-compulsive disorder in adults: a systematic review and meta-analysis of randomized clinical trials

in Psychopharmacology

Shayan Eghdami
Negin Eissazade
Mohsen Heidari Mokarar
Mahsa Boroon
Laura Orsolini
Mohammadreza Shalbafan

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1421150

11,268 views
3 citations

Systematic Review

Published on 19 Sep 2024

Short-term safety and tolerability profile of 5-methoxy-N,N-dimethyltryptamine in human subjects: a systematic review of clinical trials

in Psychopharmacology

Aleksander Kwaśny
Alina Wilkowska
Wiesław Jerzy Cubała

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1477996

6,489 views
7 citations

Editorial

Published on 10 Sep 2024

Editorial: Cannabis and mental health: is it possible to predict safe use in the era of legalization?

in Psychopharmacology

Georgios A. Alevizopoulos
Artemis Igoumenou
Ioanna Vardakou
Aristomenis Alevizopoulos

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1468325

1,803 views
1 citation

Systematic Review

Published on 09 Sep 2024

Effects of sodium benzoate on cognitive function in neuropsychiatric disorders: a systematic review and meta-analysis

in Psychopharmacology

Chun-Wei Liang
Hsiao-Yi Cheng
Mei-Chih Meg Tseng

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1370431

4,844 views
4 citations

609 articles

articles

Lurasidone uses and dosages in Spain: RETROLUR, a real-world retrospective analysis using artificial intelligence

Treatment of neuropathic pain with repeated low-dose MDMA: a case report

Bringing MDMA-assisted therapy for PTSD to traditional healthcare systems: tending to set and setting

A systematic review and meta-analysis of the effects of combined aripiprazole on glycolipid metabolism in schizophrenia

Corrigendum: Physical disability and psychedelic therapies: an agenda for inclusive research and practice

Clinical pharmacist recommendations in daily interdisciplinary ward rounds at a psychiatric hospital: a retrospective pre-post study on drug-related problems focused in somatic comorbidities

Association between polypharmacy and the long-term prescription of hypnotics in Japan: a retrospective cross-sectional study

Phytochemicals in the treatment of patients with depression: a systemic review

Pregabalin treatment in a 30-year-old patient with Bainbridge-Ropers syndrome: a case-report

Prevalence and solving strategies of drug-related problems in adult psychiatric inpatients - a systematic review

Metformin in the management of antipsychotic-induced weight gain – why the ‘weight’?

Editorial: Women in psychiatry 2023: psychopharmacology

Vortioxetine as an alternative treatment for somatic symptom disorder: case report

Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics

Country-specific psychopharmacological risk of reporting suicidality comparing 38 antidepressants and lithium from the FDA Adverse Event Reporting System, 2017–2023

Editorial: Biological and non-pharmacological treatments of obsessive-compulsive disorder and related disorders

Hepatotoxicity of antipsychotics: an exploratory pharmacoepidemiologic and pharmacodynamic study integrating FAERS data and in vitro receptor-binding affinities

Passiflora incarnata L., herba, in benzodiazepine tapering: long-term safety and efficacy in a real-world setting

The potential of muscarinic M1 and M4 receptor activators for the treatment of cognitive impairment associated with schizophrenia

Exploring cariprazine as a treatment option for varied depression symptom clusters

The safety and efficacy of N-acetylcysteine as an augmentation in the treatment of obsessive-compulsive disorder in adults: a systematic review and meta-analysis of randomized clinical trials

Short-term safety and tolerability profile of 5-methoxy-N,N-dimethyltryptamine in human subjects: a systematic review of clinical trials

Editorial: Cannabis and mental health: is it possible to predict safe use in the era of legalization?

Effects of sodium benzoate on cognitive function in neuropsychiatric disorders: a systematic review and meta-analysis